Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$9.0 million.

  • RxSight's Cash from Investing Activities rose 276.46% to -$9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year increase of 12896.27%. This contributed to the annual value of -$99.3 million for FY2024, which is 34878.21% down from last year.
  • Per RxSight's latest filing, its Cash from Investing Activities stood at -$9.0 million for Q3 2025, which was up 276.46% from $14.7 million recorded in Q2 2025.
  • RxSight's 5-year Cash from Investing Activities high stood at $43.8 million for Q2 2022, and its period low was -$115.6 million during Q2 2024.
  • In the last 5 years, RxSight's Cash from Investing Activities had a median value of $4.4 million in 2023 and averaged -$7.2 million.
  • As far as peak fluctuations go, RxSight's Cash from Investing Activities soared by 298482.14% in 2023, and later plummeted by 273128.56% in 2024.
  • Quarter analysis of 5 years shows RxSight's Cash from Investing Activities stood at -$35.3 million in 2021, then soared by 129.44% to $10.4 million in 2022, then tumbled by 56.12% to $4.6 million in 2023, then plummeted by 71.09% to $1.3 million in 2024, then crashed by 782.12% to -$9.0 million in 2025.
  • Its last three reported values are -$9.0 million in Q3 2025, $14.7 million for Q2 2025, and $20.9 million during Q1 2025.